Safety of intravenous application of a mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer

Roman Huber,Carola Effertz,Sabine Rieger,Wilfried Tröger

Phytomedicine（2015）

引用 1|浏览7

暂无评分

摘要

BackgroundMistletoe extracts have anti-tumor properties and are approved for subcutaneous use in cancer patients. Data on Intravenous application are limited.

查看译文

关键词

mistletoe extract,intravenous application,advanced cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要